mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.2 |
mRNA |
embelin |
GDSC1000 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
Pyrimethamine |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.2 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.2 |